发明名称 |
Recovery and processing of human embryos formed in vivo |
摘要 |
A kit having instructions for use for performing uterine lavage in a female patient includes a uterine lavage catheter configured for insertion into a woman's uterus to remove viable blastocysts from the uterus, and one or more first containers having a sufficient dosage amount of a GnRH antagonist to cause desynchronization of the endometrium of the patient prior to, during and/or following recovery of viable blastocysts from the uterus. |
申请公布号 |
US9561257(B2) |
申请公布日期 |
2017.02.07 |
申请号 |
US201514814151 |
申请日期 |
2015.07.30 |
申请人 |
Previvo Genetics, Inc. |
发明人 |
Carson Sandra Ann;Buster John E.;Cesario Moses;Woodard Steven Paul |
分类号 |
A61K38/08;A61B17/435;A61B17/42;A61K38/09;A61K31/57;A61K31/215;A61K31/575;A61K31/573;A61K31/58;C12Q1/68;A61K38/24;A61K45/06;A61K9/00;A61B17/425 |
主分类号 |
A61K38/08 |
代理机构 |
Fish & Richardson P.C. |
代理人 |
Fish & Richardson P.C. |
主权项 |
1. A method of inducing corpus luteum apoptosis leading to desynchronization of the endometrium in a female patient, comprising recovering blastocysts and administering a GnRH antagonist to the patient such that corpus luteum apoptosis is induced wherein the GnRH antagonist is administered daily for up to ten days or until the onset of menses following blastocyst recovery to induce said corpus luteum apoptosis. |
地址 |
San Jose CA US |